Assembly Biosciences, Inc. (ASMB) Net margin 2017–2025
Assembly Biosciences, Inc. (ASMB) net profit margin by fiscal year — reported net income divided by reported revenue.
-8.5%FY2025 · since FY2017: -474.7% → -8.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.5% | +132.4 pp |
| FY2024 | -140.9% | +713.9 pp |
| FY2023 | -854.8% | — |
| FY2021 | -2076.4% | -1997.8 pp |
| FY2020 | -78.6% | +533.1 pp |
| FY2019 | -611.6% | +1.4 pp |
| FY2018 | -613.0% | -138.4 pp |
| FY2017 | -474.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice